K792019

Substantially Equivalent

PHADECODE XA INHIBITOR ASSAY

Applicant: Pharmaseal Div., Baxter Healthcare Corp.
Product code: JBQ
Advisory panel: Hematology
Date received: 1979-10-09
Decision date: 1979-11-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.